Compare J M Smucker Co (SJM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs State Street SPDR S&P Biotech ETF — how do they compare? J M Smucker Co trades at $112.69 (market cap $11.97B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: J M Smucker Co pays a 3.93% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| SJM | XBI | |
|---|---|---|
Market Cap | $11.97B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $117.05 | $164.28 |
52-Week Low | $89.53 | $85.16 |
Enterprise Value | $19.00B | — |
Dividend Yield | 3.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
